| 1.62 -0.04 (-2.41%) | 02-20 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.56 | 1-year : | 2.99 |
| Resists | First : | 2.19 | Second : | 2.55 |
| Pivot price | 1.89  |
|||
| Supports | First : | 1.6 | Second : | 1.33 |
| MAs | MA(5) : | 1.66 |
MA(20) : | 1.98 |
| MA(100) : | 3.01 |
MA(250) : | 6 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 6.6 |
D(3) : | 6.6 |
| RSI | RSI(14): 30.8 |
|||
| 52-week | High : | 21 | Low : | 1.6 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ GOCO ] has closed above bottom band by 17.7%. Bollinger Bands are 5.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.65 - 1.66 | 1.66 - 1.67 |
| Low: | 1.58 - 1.59 | 1.59 - 1.6 |
| Close: | 1.6 - 1.62 | 1.62 - 1.63 |
GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Internal; and IFP and Other—External. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.
Wed, 18 Feb 2026
Public Sector Pension Investment Board Invests $8.10 Million in GoHealth, Inc. $GOCO - MarketBeat
Wed, 19 Nov 2025
William Blair downgrades GoHealth stock to Market Perform on Medicare growth pullback - Investing.com
Mon, 17 Nov 2025
GoHealth (NASDAQ: GOCO) Q3 Revenue Down 71% on Medicare Advantage Pullback - Stock Titan
Thu, 13 Nov 2025
GoHealth, Inc. Q3 2025 Financial Results - TradingView
Tue, 11 Nov 2025
GoHealth, Inc. to Announce Third Quarter 2025 Financial Results on November 13 - Quiver Quantitative
Thu, 06 Nov 2025
GoHealth, Inc. (NASDAQ:GOCO) has caught the attention of institutional investors who hold a sizeable 33% stake - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Insurance - Brokers
|
|
| Shares Out | 16 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 15.4 (%) |
| Held by Institutions | 61.1 (%) |
| Shares Short | 462 (K) |
| Shares Short P.Month | 324 (K) |
| EPS | -16.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.25 |
| Profit Margin | -27 % |
| Operating Margin | -239.2 % |
| Return on Assets (ttm) | -2.1 % |
| Return on Equity (ttm) | -171.1 % |
| Qtrly Rev. Growth | -71.1 % |
| Gross Profit (p.s.) | 36.93 |
| Sales Per Share | 45.88 |
| EBITDA (p.s.) | 3.64 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -68 (M) |
| Levered Free Cash Flow | 44 (M) |
| PE Ratio | -0.1 |
| PEG Ratio | 0 |
| Price to Book value | 0.38 |
| Price to Sales | 0.03 |
| Price to Cash Flow | -0.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|